They discuss CTSC funding opportunities and the collaborative efforts that have advanced Dr. Gurkan's research and international clinical studies on sickle cell disease. Plus, learn more about the ...
Are you a member? To ensure you are receiving the latest information from the CTSC, fill out a brief survey to connect with us and learn more about events, funding, and resources that the CTSC has to ...
The CTSC opened 906 patient cases during this time frame. Among all US patients with a closed case (n = 750), the clinical trial enrollment rate was 16.1%. Among those with a known enrollment outcome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results